Sanofi and Regeneron announced on Monday, Feb. 11 alirocumab will be made available at a reduced list price to help lower patient out-of-pocket costs and improve access.
Alan Brown, MD, FNLA
It has been an honor to serve as the President of the National Lipid Association (NLA) for the 2018-19 organizational year, and I look forward to the rest of my term through the 2019 Scientific Sessions. I hope everyone had a wonderful holiday and want to wish everyone a Happy New Year. I am excited for what 2019 has in store.
The NLA has released its clinician tear sheet on the 2018 Guideline on the Management of Blood Cholesterol.
The tear sheet is an important resource for physicians to quickly and easily reference key points from the 2018 Guideline at a glance. It can be printed or shared electronically for reference at physician practices in addition to being shared among colleagues.
Check back later for more NLA clinical resources and tools related to the 2018 Guideline.